Redcare Pharmacy stock: third-quarter update on October 29, 2026, pre-market little changed
Published on 10/19/2026 at 07:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSUpcoming company calendar
- Redcare Pharmacy has scheduled its third-quarter interim statement for October 29, 2026.
- The AEX is the relevant benchmark for October 19, 2026.
- Redcare Pharmacy stock trades pre-market at EUR 74.70 at 7:30 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.13 percent below the Xetra close of October 16, 2026.
Redcare Pharmacy has scheduled its third-quarter interim statement for October 29, 2026, according to the company’s investor-relations calendar. Redcare Pharmacy stock trades pre-market at EUR 74.70 at 7:30 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.13 percent below the Xetra close of October 16, 2026 (EUR 74.80).
Next quarterly update
The company’s calendar lists a third-quarter interim statement for October 29, 2026. The date is the next scheduled company event identified on the investor-relations site.
Ahead of the Xetra open
The stock is EUR 0.10 below the Xetra close. Bid was EUR 74.25 and ask EUR 75.15, a spread of 1.20 percent. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Redcare Pharmacy stock.
The group and its market
Redcare Pharmacy operates an online pharmacy that sells prescription and nonprescription medicines through e-commerce. The company’s next scheduled update is the third-quarter interim statement on October 29, 2026. Market context: Market report AEX.
